Metagenomi GAAP EPS of -$2.36 in-line, revenue of $25.2M misses by $3.43M
Source: SeekingAlpha
2026-03-05 17:00:48 ET
More on Metagenomi
- Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Seeking Alpha’s Quant Rating on Metagenomi
- Historical earnings data for Metagenomi
- Financial information for Metagenomi
Read the full article on Seeking Alpha
For further details see:
Metagenomi GAAP EPS of -$2.36 in-line, revenue of $25.2M misses by $3.43M
Metagenomi Inc.
NASDAQ: MGX
MGX Trading
13.7% G/L:
$1.7907 Last:
430,240 Volume:
$1.59 Open:
MGX Latest News
March 05, 2026 04:05:00 pm
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
February 23, 2026 04:05:00 pm
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
MGX Stock Data
$58,948,399
30,863,429
9%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
